Stay updated on Troriluzole for Spinocerebellar Ataxia Clinical Trial
Sign up to get notified when there's something new on the Troriluzole for Spinocerebellar Ataxia Clinical Trial page.

Latest updates to the Troriluzole for Spinocerebellar Ataxia Clinical Trial page
- Check6 days agoChange DetectedRevision history updated to include Revision: v3.4.3 and remove Revision: v3.4.2.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedRevision v3.4.2 was added. The notice about government funding status and Revision v3.4.1 were removed.SummaryDifference0.4%

- Check41 days agoChange DetectedAdded a system notice about potential delays due to government funding lapses and updated the site revision to v3.4.1 (replacing v3.4.0).SummaryDifference0.4%

- Check48 days agoChange DetectedThe record history page now includes UI clarifications about color-coded changes (green for additions, red for deletions) and shows the glossary option and updated revision notes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check63 days agoChange DetectedThe revision history now includes a new entry for v3.3.4 and removes v3.3.3, reflecting an administrative update to the page's version history.SummaryDifference0.1%

- Check84 days agoChange DetectedNew revision: v3.3.3 is now listed in the study record history, and the HHS Vulnerability Disclosure link and the Revision: v3.3.2 item were removed from the footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Troriluzole for Spinocerebellar Ataxia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Troriluzole for Spinocerebellar Ataxia Clinical Trial page.